These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23193144)

  • 1. Pharmacological treatment of heart failure with preserved ejection fraction: a glimpse of light at the end of the tunnel?
    van Veldhuisen DJ; McMurray JJ
    Eur J Heart Fail; 2013 Jan; 15(1):5-8. PubMed ID: 23193144
    [No Abstract]   [Full Text] [Related]  

  • 2. Aldosterone blockade in patients with heart failure and a reduced left ventricular ejection fraction.
    Pitt B
    Eur Heart J; 2009 Feb; 30(4):387-8. PubMed ID: 19190013
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diastolic dysfunction and diastolic heart failure].
    Rossi G
    Recenti Prog Med; 2007; 98(7-8):407-16. PubMed ID: 17685191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of heart failure with normal ejection fraction in patients with advanced chronic heart failure.
    Martinez-Selles M
    Eur J Heart Fail; 2007 Dec; 9(12):1223; author reply 1224-5. PubMed ID: 18006377
    [No Abstract]   [Full Text] [Related]  

  • 5. Heart failure with preserved left ventricular ejection fraction: concepts, misconceptions and future directions.
    Soma J
    Blood Press; 2011 Jun; 20(3):129-33. PubMed ID: 21142436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should treatment for heart failure with preserved ejection fraction differ from that for heart failure with reduced ejection fraction?
    Jong P; McKelvie R; Yusuf S
    BMJ; 2010 Aug; 341():c4202. PubMed ID: 20739364
    [No Abstract]   [Full Text] [Related]  

  • 7. Heart failure with normal left ventricular ejection fraction: what is the evidence?
    Kindermann M; Reil JC; Pieske B; van Veldhuisen DJ; Böhm M
    Trends Cardiovasc Med; 2008 Nov; 18(8):280-92. PubMed ID: 19345315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
    Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Favourable effects of heart rate reduction with intravenous administration of ivabradine in patients with advanced heart failure.
    De Ferrari GM; Mazzuero A; Agnesina L; Bertoletti A; Lettino M; Campana C; Schwartz PJ; Tavazzi L
    Eur J Heart Fail; 2008 Jun; 10(6):550-5. PubMed ID: 18486549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of left ventricular diastolic dysfunction to heart failure regardless of ejection fraction.
    Brucks S; Little WC; Chao T; Kitzman DW; Wesley-Farrington D; Gandhi S; Shihabi ZK
    Am J Cardiol; 2005 Mar; 95(5):603-6. PubMed ID: 15721099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart failure with preserved ejection fraction.
    Udelson JE
    Circulation; 2011 Nov; 124(21):e540-3. PubMed ID: 22105201
    [No Abstract]   [Full Text] [Related]  

  • 12. Treating diastolic heart failure: the role of calcium antagonists.
    Coutinho J
    Rev Port Cardiol; 1999 Sep; 18 Suppl 5():V111-6. PubMed ID: 10582472
    [No Abstract]   [Full Text] [Related]  

  • 13. Relation of sex to morbidity and mortality in patients with heart failure and reduced or preserved left ventricular ejection fraction.
    Alla F; Al-Hindi AY; Lee CR; Schwartz TA; Patterson JH; Adams KF
    Am Heart J; 2007 Jun; 153(6):1074-80. PubMed ID: 17540212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diastolic cardiac insufficiency].
    Spoto S; Palma Modoni A; De Galasso L
    Clin Ter; 2002; 153(5):355-7. PubMed ID: 12510423
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanistic and clinical rationales for using beta-blockers in heart failure.
    Bristow MR
    J Card Fail; 2000 Jun; 6(2 Suppl 1):8-14. PubMed ID: 10908093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [NMR shows how beta blockers change the failing ventricle. Decreased size and better output performance].
    MMW Fortschr Med; 2003 Jun; 145(25):56. PubMed ID: 12891860
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study.
    Yamada T; Node K; Mine T; Morita T; Kioka H; Tsukamoto Y; Tamaki S; Masuda M; Okuda K; Fukunami M
    Am Heart J; 2007 Jun; 153(6):1055.e1-8. PubMed ID: 17540209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diastolic dysfunction and heart failure with preserved ejection fraction in women.
    Piña IL
    Arch Intern Med; 2011 Jun; 171(12):1088-9. PubMed ID: 21709108
    [No Abstract]   [Full Text] [Related]  

  • 19. beta-Blocker therapy in heart failure.
    Doughty RN
    Heart Fail Monit; 2000; 1(1):2-7. PubMed ID: 12634875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of angiotensin-converting enzyme inhibition on functional class in patients with left ventricular systolic dysfunction--a meta-analysis.
    Abdulla J; Pogue J; Abildstrøm SZ; Køber L; Christensen E; Pfeffer MA; Yusuf S; Torp-Pedersen C
    Eur J Heart Fail; 2006 Jan; 8(1):90-6. PubMed ID: 16054435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.